__NUXT_JSONP__("/drugs/Allogeneic_Natural_Killer_Cell_Line_MG4101", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A population of allogeneic, cytotoxic natural killer (NK) cells with potential antitumor activity. Allogeneic natural killer cell line MG4101 is derived from cells of a normal, healthy donor upon leukapheresis and activation.",fdaUniiCode:"WX2ZW10GHO",identifier:"C94209",preferredName:c,semanticType:"Cell",subclassOf:["C129826","C28676"],synonyms:["Allogeneic NK Cell Line MG4101",c,"MG-4101","MG4101"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAllogeneic_Natural_Killer_Cell_Line_MG4101",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Allogeneic_Natural_Killer_Cell_Line_MG4101","Allogeneic Natural Killer Cell Line MG4101","2021-10-30T13:47:44.043Z")));